DXCM
★★★☆☆ WatchopenrouterDexCom, Inc.
Healthcare
Session move
$89.60
Vol 0.59× avg
76/100 quant · tgt $94.12
RS60 +21.0% vs SPY · ADV$ 447.8M
pushed 2026-08-19T10:25 · Pre-market · Pushed snapshot
Since last scan
2026-08-18 → 2026-08-19
Context only — not a buy/sell signal. Built from scan history and cached news/filings.
Snapshot quote
session 2026-08-18 · scan 2026-08-19 · pushed 2026-08-19T10:25 · Pre-market
Show quote fundamentalsHide quote fundamentals
- Last (scan/close)
- $89.60
- Previous close
- $88.76
- Pushed last
- $89.60 · Pre-market
- Session open
- $89.49
- Last session range
- $88.98 – $91.50
- 52-week range
- $54.11 – $91.96
- Session volume
- 3,199,079
- Avg volume (20d)
- 5,391,149
- Market cap
- $33.81B
- PE (TTM)
- 35.42
- Forward PE
- 28.68
- Dividend yield
- 0.00%
- 1y target est.
- $94.12
- Next earnings
- 2026-10-29
Snapshot quote — last daily session bars and scan fundamentals. Not live bid/ask or intraday quotes. Pre/after-hours quotes are thinner and may differ from the regular session.
If you put $1,000 in
1y ago
$1,108
+11%
5y ago
$691
−31%
Price path only from cached daily closes (adjusted when available). Not dividends cash, fees, or advice.
Market briefing
Curated digest — not a trade signal. Headlines and links as provided by the producer.
- DexCom (DXCM) Rebounds On Growth Hopes, Does It Look Fully Valued?
DexCom stock reacts to recent performance and fundamentals DexCom (DXCM) has attracted investor attention after a recent share price move, with the stock closing at US$89.75. The company’s returns over the past month and past 3 months now stand out against its longer term record. See our latest analysis for DexCom. Short term momentum in DexCom has been strong, with the 30 day share price return of 17.09% and the 90 day share price return of 34.06% contrasting with a more modest 1 year total...
Yahoo · 2026-08-17
- DexCom (DXCM) Stock Sees Modest Fair Value Lift After Q2 And Clinical Updates
DexCom’s latest analyst work shows a modest lift in the modelled fair value, with the price target figure moving from US$91.64 to US$94.12. This adjustment sits alongside mixed analyst commentary that balances positive Q2 2026 execution, new clinical data and guidance updates, and ongoing questions about valuation and sector sentiment. As you read on, you will see how these moving parts shape the current story around DexCom and how to keep track of future shifts in the narrative. Stay updated...
Yahoo · 2026-08-17
- 1 Surging Stock Worth Your Attention and 2 We Question
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage have propelled their returns.
Yahoo · 2026-08-17
Reddit mentions
Public Reddit titles via the official API — unofficial, delayed, not a trade signal. Not affiliated with Reddit. Opens Reddit.
No recent Reddit titles matched this ticker.
Price Chart
Daily prices from cache
Loading price history…
AI Analysis
- Bull Thesis — DexCom, Inc. is poised for growth driven by strong EPS growth of 16% YoY and a robust revenue growth forecast, supported by increasing adoption of continuous glucose monitoring technology.
- Risks — The company faces risks related to insider selling, as indicated by recent form 4 filings, which may impact investor confidence.
- Target Upside — With a current price of $89.60 and a mean target price of $94.12, there is approximately 5% upside potential.
Score History
15 days of scans. Daily batch adds the next weekday automatically while the API is running.
- DatePriceChgScoreRating
- 2026-08-19$89.60+0.8476.0Watch
- 2026-08-18$88.76-0.9976.9Watch
- 2026-08-17$89.75-1.7376.3Watch
- 2026-08-14$91.48+0.1975.7Watch
- 2026-08-13$91.29+1.7675.8Watch
- 2026-08-12$89.53+1.8876.6Watch
- 2026-08-11$87.65+2.9078.3Watch
- 2026-08-10$84.75+1.7379.2Watch
- 2026-08-07$83.02+0.3679.8Watch
- 2026-08-06$82.66-4.2880.5Buy
- 2026-08-05$86.94-0.3777.6Watch
- 2026-08-03$87.31+3.8677.3Watch
- 2026-08-01$83.45+0.7079.4Watch
- 2026-07-31$82.75+8.2177.3Watch
- 2026-07-30$74.54—82.1Buy
Quant Breakdown
Short volume (FINRA)
Off-exchange short sale volume ratio vs recent sessions — not a squeeze forecast.
- Short / total
- 50.2%
- vs 20d (z)
- -0.61
- Short vol
- 543,188
- Status
- ok
Squeeze pressure score
full25/100
- Short leg
- 7
- Call leg
- 59
- Activity
- 0.0
- Call vol share
- 53.8%
- PCR (vol)
- 0.86
- Call OI share
- 75.1%
- ATM IV
- 54.5%
FINRA off-exchange short volume (TRF/ADF consolidated). Not short interest as % of float. Squeeze pressure score (0–100) — free composite of off-exchange short volume and (when available) call-side options activity. Not a probability that a squeeze will occur.
Disclosure score
Rule-based News / Insider / Earnings legs from cached SEC filings — context only, not beat/miss or a buy signal.
Disclosure score
-15
- News
- 0
- Insider
- -15
- Earnings
- 0
Signals below are rule hits from cached filings — Risk / Constructive / Attention. Attention is not a bullish call. Linked chips open the SEC original when available.
Disclosure event score — rule-based view of recent SEC filings and earnings calendar. Not a prediction that price will move, and not earnings beat/miss.
Earnings surprise (quant context)
From Yahoo/public fundamentals cached on the last quant scan — not part of the disclosure event score, and not a buy signal. Figure can lag the latest print.
Last reported surprise +0.4%
Filings & events
Recent SEC disclosures and earnings dates — context only, not a trade signal.
- Next earnings
- 2026-10-29yahoo_calendar
- Last earnings
- —
- SEC ↗42026-08-17
FORM 4
- SEC ↗42026-08-13
FORM 4
- SEC ↗42026-08-13
FORM 4
- SEC ↗42026-08-04
FORM 4
- SEC ↗10-Q2026-07-30
10-Q
- SEC ↗8-K2026-07-30
8-K
- SEC ↗42026-07-21
FORM 4
- SEC ↗42026-07-16
FORM 4
- SEC ↗42026-07-07
FORM 4
- SEC ↗42026-06-17
FORM 4
SEC filings as reported; earnings dates may come from Yahoo calendar. Context only — not investment advice and not a prediction that price will move on a filing or event.